Author

Renee Kirk

Observed name: Renee A. Kirk

Institution: Vaccinex (United States)

Observed institution: Vaccinex (United States)

OpenAlex ID: A5111030711

SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease

2014 · Ernest S. Smith, Alan Jonason, et al. · Neurobiology of Disease · 121

Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies

2015 · Elizabeth E. Evans, Alan S. Jonason, et al. · Cancer Immunology Research · 111

Generation and preclinical characterization of an antibody specific for SEMA4D

2015 · Terrence L. Fisher, Christine A. Reilly, et al. · mAbs · 55

Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations

2015 · Elizabeth E Evans, Siwen Hu-Lieskovan, et al. · Journal for ImmunoTherapy of Cancer · 3

Use of poxvirus display to select antibodies specific for complex membrane antigens

2023 · Ernest S. Smith, Leslie A. Balch, et al. · mAbs · 2

Abstract 1245: Reduction of tumor growth and metastasis by a humanized IgG4 monoclonal antibody to SEMA4D (VX15/2503).

2013 · Elizabeth E. Evans, Alan S. Jonason, et al. · Cancer Research · 1

Abstract 2531: Reduction of In Vivo Tumor Growth and Angiogenesis by a Humanized IgG4 Monoclonal Antibody to SEMA4D

2012 · Alan S. Jonason, Terrence L. Fisher, et al. · Cancer Research · 1

Abstract LB-C007: Enhancing immune interactions in tumor with pepinemab SEMA4D blocking antibody

2026 · Elizabeth E. Evans, Crystal Mallow, et al. · Cancer Immunology Research

Targeting SEMA4D/PLXN signaling through reactive glia as a common pathology for the treatment of neurodegenerative disorders

2025 · Elizabeth E Evans, Terrence L Fisher, et al. · Alzheimer s & Dementia

1100 Discovery of high affinity functional antibodies specific for CXCR5, P2X7 and other multi-pass membrane receptors

2024 · Ernest Smith, Elizabeth Evans, et al. · Regular and Young Investigator Award Abstracts

Supplementary Methods and Figure Legends from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies

2023 · Elizabeth E. Evans, Alan S. Jonason, et al.

Supplementary Figures 1-8 from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies

2023 · Elizabeth E. Evans, Alan S. Jonason, et al.

Data from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies

2023 · Elizabeth E. Evans, Alan S. Jonason, et al.

Supplementary Methods and Figure Legends from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies

2023 · Elizabeth E. Evans, Alan S. Jonason, et al.

Supplementary Figures 1-8 from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies

2023 · Elizabeth E. Evans, Alan S. Jonason, et al.

Data from Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies

2023 · Elizabeth E. Evans, Alan S. Jonason, et al.

Abstract 4888: Antibody blockade of semaphorin 4D breaks down stromal barriers to enhance tumoricidal immune infiltration, supporting rational immunotherapy combinations

2016 · Elizabeth E. Evans, Holm Bussler, et al. · Cancer Research

Abstract A119: Antibody blockade of Semaphorin 4D neutralizes barrier to immune infiltration and facilitates immune-mediated tumor rejection

2016 · Elizabeth E. Evans, Holm Bussler, et al. · Cancer Immunology Research

Antibody blockade of Semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations

2015 · Elizabeth Evans, Siwen Hu-Lieskovan, et al.

Abstract A67: Phase 1 study of VX15/2503, an immunomodulatory antibody to Semaphorin 4D that reverses tumor growth in preclinical studies

2015 · Elizabeth E. Evans, Terrence L. Fisher, et al. · Cancer Immunology Research

Abstract 278: Antibody blockade of semaphorin 4D promotes infiltration of activated tumor infiltrating leukocytes and reverses tumor growth

2015 · Elizabeth E. Evans, Holm Bussler, et al. · Cancer Research

Antibody blockade of semaphorin 4D promotes infiltration of activated tumor infiltrating leukocytes and inhibits tumor growth. (TUM7P.1030)

2015 · Ekaterina Klimatcheva, Elizabeth Evans, et al. · The Journal of Immunology

Development of anti-CXCL13 monoclonal antibody for the treatment of autoimmune and immuno-oncological disorders (THER2P.950)

2015 · Ekaterina Klimatcheva, Crystal Mallow, et al. · The Journal of Immunology

Abstract 5030: Antibody blockade of Semaphorin 4D promotes tumor rejection and improves response to immune checkpoint blockade and chemotherapy

2014 · Elizabeth E. Evans, Holm Bussler, et al. · Cancer Research

Abstract 3667: Reduction of in vivo tumor growth and angiogenesis by a humanized IgG4 monoclonal antibody to SEMA4D

2011 · Alan S. Jonason, Terrence L. Fisher, et al. · Cancer Research

Works count: 26

Citation count: 294

H-index: 3

I10-index: 3